Dose Effects of Recombinant Human lnterleukin-6 on Pituitary Hormone Secretion and Energy Expenditure
The DOI matches its Crossref record.
Abstract
Interleukin-6 (IL-6), the main circulating cytokine, is putatively a major mediator of the effects of the immune system on several endocrine axes and intermediate metabolism. We performed dose-response studies of recombinant human IL·6 on pituitary hormone secretion in 15 healthy male volunteers, using 5 single, escalating subcutaneous doses of IL-6 (0.1, 0.3, 1.0, 3.0 and 10.0 µg/kg body weight), each in 3 volunteers. We measured resting metabolic rate (RMR) with indirect calorimetry and plasma anterior pituitary hormones and vasopressin (AVP) at baseline and half-hourly over 4 h after the injection. All doses examined were tolerated well and produced no significant adverse effects. Dose-dependent RMR increases were observed in response to the 3.0- and 10.0-µg/kg doses of IL-6, beginning at 60 min and slowly peaking between 180 and 240 min. Plasma adrenocorticotropic-hormone concentrations increased dramatically and dose-dependently in all the patients who received the 3.0- and 10.0-µg/kg doses of IL-6, respectively, peaking to 150 and 255 pg/ml at 60 min, and slowly returning to normal by 4 h. Corresponding plasma cortisol levels peaked dose-dependently between 90 and 150 min, but remained elevated throughout the sampling period. In contrast, the growth hormone (GH) dose-response was bell-shaped, with maximum (approximately 100-fold) stimulation achieved by 3.0 µg/kg IL-6. Prolactin (PRL) showed a similar but less pronounced response pattern. Thyroid-stimulating hormone (TSH) dose-dependently and progressively decreased over the 240 min, while gonadotropins showed no clear-cut changes. In conclusion, subcutaneous IL-6 administration induced synchronized dose-dependent increases in the RMR and hypothalamic-pituitary-adrenal axis activity, suggesting that hypothalamic corticotropin-releasing hormone may mediate both of these functions in humans. IL-6 also acutely stimulated GH and PRL secretion and suppressed TSH secretion. The dose of 3.0 µg/kg could be used safely in the study of patients with disturbances of the hypothalamic-pituitary unit or of thermogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic smoldering inflammation in humans is already established with elevations of serum IL-6 from normal levels of 1 pg/mL to approximately 10 to 100 pg/mL of serum IL-6, leading to an increase of resting metabolic rate in healthy volunteers [8].”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [8]
In the citing paper
“In these settings, circulating cytokine levels can be 5 to 10 times higher than normal (e.g., IL-6 from 2 pg/ml to 10–20 pg/ml), and the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [42]
In the citing paper
“the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [42]
In the citing paper
“IL-6 and TNF-α stimulate secretion of cortisol and, in turn, cortisol inhibits their secretion.84”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [84]
Citations
Cited by
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822
Self-citationTrade‐offs in evolutionary immunology: just what is the cost of immunity?
Lochmiller, R. L., & Deerenberg, C. (2000) · Oikos · doi:10.1034/j.1600-0706.2000.880110.x · Cited by 2,110
“The monokines interleukin-1 (IL-1), IL-6, and tumour necrosis factor-a (TNF-a) are the primary cellular messengers triggering the cascade of metabolic alterations following an immune challenge (Klasing and Johnstone 1991, Tsigos et al. 1997).”
BackgroundRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146
Self-citationAdipose tissue as an endocrine and paracrine organ
Mohamed-Ali, V, Pinkney, J., & Coppack, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800770 · Cited by 999
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
“In humans, IL-6 administration has been shown to induce a synchronized dose-dependent increase in resting metabolic rate and HPA activity, suggesting that hypothalamic CRH may mediate both of these functions (167).”
BackgroundInfluentialMetabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
“A role for I-L6 in energy expenditure and improved glucose uptake in rodents and humans is previously supported (101, 647).”
Interleukin-6 in acute exercise and training: what is the biological relevance?
Fischer, C. P. (2026) · PubMed · doi:10.22029/eir.2006.1620 · Cited by 825
CHROUSOS, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09006.x · Cited by 711
Self-citationStress hormones: physiological stress and regulation of metabolism
Kyrou, I., & Tsigos, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.007 · Cited by 431
“play a critical role in the immune stimulation of the HPA axis (Figure 2) [35,36].”
BackgroundSelf-citationStress, Visceral Obesity, and Metabolic Complications
KYROU, I., CHROUSOS, G. P., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.008 · Cited by 380
Self-citationInterleukin-6 as a key player in systemic inflammation and joint destruction
Fonseca, J. E., Santos, M. J., Canhão, H., & Choy, E. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.01.012 · Cited by 375
Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Self-citationRedwine, L., Hauger, R. L., Gillin, J. C., & Irwin, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6871 · Cited by 372
“IL-6 is known to have a stimulating influence on the secretory activity of the HPA axis (15, 29, 30).”
BackgroundArafah, B. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0674 · Cited by 332
The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective
Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.04.002 · Cited by 326
Greenberg, A. S., & McDaniel, M. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.4.x · Cited by 290
Exercise and the stress system.
Mastorakos, G. P., Pavlatou, M. G., Diamanti‐Kandarakis, E., & Chrousos, G. P. (2005) · PubMed · Cited by 380
Self-citationPlasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder
Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., Chrousos, G. P., & Geracioti Jr., T. D. (2001) · Neuroimmunomodulation · doi:10.1159/000049028 · Cited by 238
Self-citationTsigos, C., Kyrou, I., Chala, E., Tsapogas, P., Stavridis, J. C., Raptis, S. A., & Katsilambros, N. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90277-9 · Cited by 233
Self-citationStress: Endocrine Physiology and Pathophysiology
Tsigos, C., Kyrou, I., Kassi, E., & Chrousos, G. P. (2020) · PubMed · Cited by 302
Self-citationIL-6 selectively stimulates fat metabolism in human skeletal muscle
Wolsk, E., Mygind, H., Grøndahl, T. S., Pedersen, B. K., & van Hall, G. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00328.2010 · Cited by 221
Geriatric cachexia: the role of cytokines
Yeh, S.-S., & Schuster, M. W. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.70.2.183 · Cited by 219
Liu, Y., Chen, Z., Dai, J., Yang, P., Xu, W., Ai, Q., Zhang, W., Zhang, Y., Zhang, Y., & Mai, K. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.02.064 · Cited by 208
The teleost head kidney: Integrating thyroid and immune signalling
Geven, E. J. W., & Klaren, P. H. M. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.06.025 · Cited by 203
“Interleukin-6 suppresses plasma TSH levels in human in vivo (Stouthard et al., 1994; Torpy et al., 1998; Tsigos et al., 1997) and experimentally hypothyroid rats (Bartalena et al., 1994b).”
BackgroundMastocytosis: current concepts in diagnosis and treatment
L., E., C., A., M., C., A., O., & D., M. (2002) · Annals of Hematology · doi:10.1007/s00277-002-0575-z · Cited by 201
“body temperature and metabolic rate [42].”
The brain and immune system prompt energy shortage in chronic inflammation and ageing
Straub, R. H. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.172 · Cited by 192
Interacting epidemics? Sleep curtailment, insulin resistance, and obesity
Lucassen, E. A., Rother, K. I., & Cizza, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06655.x · Cited by 191
β-Adrenergic Regulation of IL-6 Release from Adipose Tissue:In Vivo and in Vitro Studies
Mohamed-Ali, V., Flower, L., Sethi, J., Hotamisligil, G., Gray, R., Humphries, S. E., York, D. A., & Pinkney, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8104 · Cited by 190
Sodium butyrate maintains growth performance by regulating the immune response in broiler chickens
Zhang, W. H., Jiang, Y., Zhu, Q. F., Gao, F., Dai, S. F., Chen, J., & Zhou, G. H. (2011) · British Poultry Science · doi:10.1080/00071668.2011.578121 · Cited by 187
“The pro-inflammatory cytokines such as IL-1 , IL-6, and TNF-a, produced and released by macrophages, are the primary cellular messengers triggering the cascade of metabolic alterations following the innate immune response (Klasing and Johnstone, 1991; Tsigos et al., 1997).”
BackgroundStrenuous exercise decreases the percentage of type 1 T cells in the circulation
Steensberg, A., Toft, A. D., Bruunsgaard, H., Sandmand, M., Halkjær-Kristensen, J., & Pedersen, B. K. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1708 · Cited by 184
“(16) demonstrated that infusion of recombinant human IL-6 into humans increases the levels of glucocorticoids.”
BackgroundStraub, R. H., Paimela, L., Peltomaa, R., Schölmerich, J., & Leirisalo‐Repo, M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10177 · Cited by 183
Muehlenbein, M. P., Hirschtick, J. L., Bonner, J. Z., & Swartz, A. M. (2010) · American Journal of Human Biology · doi:10.1002/ajhb.21045 · Cited by 178
“Thyroid hormones and several cytokines, particularly tumor necrosis factor-a and interleukin-6, play important roles in altering RMR (de Lange et al., 2001; Freake and Oppenheimer, 1995; Johnstone et al., 2005; Matarese and La Cava, 2004; Stouthard et al., 1995; Tsigos et al., 1997).”
BackgroundEndocrine responses of the stress system to different types of exercise
Athanasiou, N., Bogdanis, G. C., & Mastorakos, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09758-1 · Cited by 176
Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis
IONESCU, A. A., NIXON, L. S., EVANS, W. D., STONE, M. D., LEWIS-JENKINS, V., CHATHAM, K., & SHALE, D. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910118 · Cited by 170
Straub, R. H. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1340 · Cited by 170
Metabolic effects of interleukin-6 in human splanchnic and adipose tissue
Lyngsø, D., Simonsen, L., & Bülow, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021022 · Cited by 119
“However, this is not likely since administration of IL-6 subcutaneously gave rise to a rapid increase in the circulating IL-6 concentration which began ~15 min after the injection (Tsigos et al. 1997a,b).”
BackgroundResultExercise Improves Insulin and Leptin Sensitivity in Hypothalamus of Wistar Rats
Flores, M. B. S., Fernandes, M. F. A., Ropelle, E. R., Faria, M. C., Ueno, M., Velloso, L. A., Saad, M. J. A., & Carvalheira, J. B. C. (2006) · Diabetes · doi:10.2337/db05-1622 · Cited by 153
RetractedKermani, T. A., & Warrington, K. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60680-1 · Cited by 172
Glucocorticoids and chronic inflammation
Straub, R. H., & Cutolo, M. (2016) · Rheumatology · doi:10.1093/rheumatology/kew348 · Cited by 149
The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity
Kubaszek, A., Pihlajamäki, J., Punnonen, K., Karhapää, P., Vauhkonen, I., & Laakso, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.558 · Cited by 147
“Additionally, a subcutaneous injection of IL-6 increased resting metabolic rate and hypothalamic-pituitary-adrenal axis activity in a dose-dependent fashion, suggesting that hypothalamic corticotrophin–releasing hormone may mediate both of these actions in humans (8).”
BackgroundReduced Exercise Endurance in Interleukin-6-Deficient Mice
Fäldt, J., Wernstedt, I., Fitzgerald, S. M., Wallenius, K., Bergström, G., & Jansson, J.-O. (2004) · Endocrinology · doi:10.1210/en.2003-1319 · Cited by 143
“This finding is in accordance with earlier studies demonstrating that IL-6 treatment enhances energy expenditure in both rodents and humans (15, 17, 35, 36).”
ResultInterleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
Lang Lehrskov, L., Lyngbaek, M. P., Soederlund, L., Legaard, G. E., Ehses, J. A., Heywood, S. E., Wewer Albrechtsen, N. J., Holst, J. J., Karstoft, K., Pedersen, B. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.008 · Cited by 135
Stress, Cortisol, and Periodontitis in a Population Aged 50 Years and Over
Hilgert, J. B., Hugo, F. N., Bandeira, D. R., & Bozzetti, M. C. (2006) · Journal of Dental Research · doi:10.1177/154405910608500408 · Cited by 141
“In the early 1990s, it also became apparent that cytokines and other humoral mediators of inflammation are potent activators of the central stress response (Tsigos et al., 1997).”
BackgroundFatigue in inflammatory rheumatic diseases: current knowledge and areas for future research
Davies, K., Dures, E. K., & Ng, W. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00692-1 · Cited by 162
Li, G., Klein, R. L., Matheny, M. E., King, M. A., Meyer, E. M., & Scarpace, P. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00447-5 · Cited by 146
Corticotropin-releasing hormone regulates IL-6 expression during inflammation
Venihaki, M., Dikkes, P., Carrigan, A., & Karalis, K. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12869 · Cited by 132
“Prolonged administration of IL-6 in humans led to adrenal enlargement (17, 18), and identification of IL-6 receptors in the adrenal cortex in mice has been postulated to mediate direct stimulatory effects of IL-6 on glucocorticoid release in this species (13).”
BackgroundInfection, immunity and the neuroendocrine response
Borghetti, P., Saleri, R., Mocchegiani, E., Corradi, A., & Martelli, P. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.01.013 · Cited by 128
“Indeed, GH is able to increase IL-6, IL-2 and GM-CSF expression in the thymus (Savino et al., 2003) and in turn, IL-6 may regulate GH secretion (Tsigos et al., 1997).”
BackgroundHormonal regulation of interleukin-6 production in human adipocytes
Vicennati, V., Vottero, A., Friedman, C., & Papanicolaou, D. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802035 · Cited by 134
Self-citationEyileten, C., Kapłon‐Cieślicka, A., Mirowska-Guzel, D. M., Małek, Ł. A., & Postula, M. A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2823671 · Cited by 136
“Early human study reported that single peripheral administration of IL-6 enhanced energy expenditure in healthy volunteers [74].”
BackgroundInteraction of the endocrine system with inflammation: a function of energy and volume regulation
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4484 · Cited by 121
“Chronic smoldering inflammation in humans is already established with elevations of serum IL-6 from normal levels of 1 pg/mL to approximately 10 to 100 pg/mL of serum IL-6, leading to an increase of resting metabolic rate in healthy volunteers [8].”
BackgroundMargeli, A., Skenderi, K., Tsironi, M., Hantzi, E., Matalas, A.-L., Vrettou, C., Kanavakis, E., Chrousos, G., & Papassotiriou, I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2346 · Cited by 118
Self-citationBriken, S., Rosenkranz, S. C., Keminer, O., Patra, S., Ketels, G., Heesen, C., Hellweg, R., Pleß, O., Schulz, K., & Gold, S. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.007 · Cited by 134
“In contrast to monocyte derived IL-6, exercise induced IL-6 is claimed to activate the hypothalamic–pituitary–adrenal (HPA) axis and thereby mediate the anti-inflammatory effects (Tsigos et al., 1997).”
Physiological, Pharmacokinetic, and Pharmacodynamic Changes in Space
Graebe, A., Schuck, E. L., Lensing, P., Putcha, L., & Derendorf, H. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004267193 · Cited by 113
Weber, D., & O’Brien, K. (2016) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587216676122 · Cited by 131
Cytokines and hormones as possible links between endocrinosenescence and immunosenescence
Straub, R. H., Miller, L. E., Schölmerich, J., & Zietz, B. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00296-4 · Cited by 118
Adiposity signals, genetic and body weight regulation in humans
Cancello, R., Tounian, A., Poitou, C., & Clément, K. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70112-x · Cited by 126
“IL6 injections also decrease body weight in non-human primates [48, 49] and in humans it enhances energy expenditure and lipid oxidation [50-53].”
BackgroundEvolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology
Straub, R. H. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0861-8 · Cited by 105
“[42, 43]).”
Jacobi, A. M., Rohde, W., Ventz, M., Riemekasten, G., Burmester, G. R., & Hiepe, F. (2001) · Lupus · doi:10.1191/096120301701549688 · Cited by 105
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4688 · Cited by 109
Torpy, D. J., Tsigos, C., Lotsikas, A. J., Defensor, R., Chrousos, G. P., & Papanicolaou, D. A. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90338-9 · Cited by 95
Self-citationStraub, R. H., Bijlsma, J. W. J., Masi, A. T., & Cutolo, M. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.008 · Cited by 93
“or by 5-fold in human volunteers administered IL-6 [37].”
BackgroundCole, C. L., Kleckner, I. R., Jatoi, A., Schwarz, E. M., & Dunne, R. F. (2018) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v3i2.65 · Cited by 104
Effect of Exercise Intensity on the Cytokine Response to an Acute Bout of Running
SCOTT, J. P. R., SALE, C., GREEVES, J. P., CASEY, A., DUTTON, J., & FRASER, W. D. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31822113a9 · Cited by 82
Benrick, A., Schéle, E., Pinnock, S. B., Wernstedt‐Asterholm, I., Dickson, S. L., Karlsson‐Lindahl, L., & Jansson, J. ‐. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01879.x · Cited by 79
Circadian rhythms in rheumatology - a glucocorticoid perspective
Spies, C. M., Straub, R. H., Cutolo, M., & Buttgereit, F. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4687 · Cited by 75
Additive metabolic costs of thermoregulation and pathogen infection
Hawley, D. M., DuRant, S. E., Wilson, A. F., Adelman, J. S., & Hopkins, W. A. (2012) · Functional Ecology · doi:10.1111/j.1365-2435.2012.01978.x · Cited by 71
Endocrine and Metabolic Alterations in Sepsis and Implications for Treatment
Ingels, C., Gunst, J., & den Berghe, G. V. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.006 · Cited by 71
Barkhudaryan, N., & Dunn, A. J. (1999) · Neurochemical Research · doi:10.1023/a:1020720722209 · Cited by 81
“Plasma ACTH and cortisol concentration are markedly increased after IL-6 administration to healthy male volunteers (3 and 10 Ug/kg) (85).”
Huntley, N. F., Nyachoti, C. M., & Patience, J. F. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-018-0264-y · Cited by 69
Perry, H. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1369 · Cited by 67
“It activates the hypothalamicpituitary-adrenal axis, increasing adrenocorticotropin and plasma cortisol (104, 105).”
BackgroundModulation of IL-6 Production during the Menstrual Cycle in Vivo and in Vitro
Konecná, L., Yan, M., Miller, L. E., Schölmerich, J., Falk, W., & Straub, R. H. (2000) · Brain Behavior and Immunity · doi:10.1006/brbi.1999.0570 · Cited by 67
Fine, J. M., Gordon, T., Chen, L., et al. (2000) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200011000-00010 · Cited by 65
Veldhuis, J., Yang, R., Roelfsema, F., & Takahashi, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3611 · Cited by 65
“The majority, but not all (22, 29), of clinical investigations of ILs have been performed in cancer patients.”
BackgroundStraub, R. H., Buttgereit, F., & Cutolo, M. (2011) · PubMed · Cited by 85
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 76
“activates the hypothalamic–pituitary–adrenal axis, thereby suggesting that CRH may be mediating this effect, as is observed in mice((141,142)).”
BackgroundGalassetti, P. R., Iwanaga, K., Crisostomo, M., Zaldivar, F. P., Larson, J. K., & Pescatello, A. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00140.x · Cited by 72
“IL-6 can, in fact, stimulate endogenous glucose production (22, 23) and GH secretion (24), while inhibiting secretion of IGF-I (23).”
BackgroundCentral Exercise Action Increases the AMPK and mTOR Response to Leptin
Ropelle, E. R., Fernandes, M. F. A., Flores, M. B. S., Ueno, M., Rocco, S., Marin, R., Cintra, D. E., Velloso, L. A., Franchini, K. G., Saad, M. J. A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003856 · Cited by 63
RetractedFrancis, K., Lewis, B. M., Akatsu, H., Monk, P. N., Cain, S. A., Scanlon, M. F., Morgan, B. P., Ham, J., & Gasque, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1103fje · Cited by 63
“Although the precise role of FS cells in pituitary physiology is unknown, one of their products, IL-6, can stimulate ACTH, GH, and PRL but not TSH secretion (38).”
BackgroundBorghetti, P., Angelis, E. D., Saleri, R., Cavalli, V., Cacchioli, A., Corradi, A., Mocchegiani, E., & Martelli, P. R. (2005) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2005.09.001 · Cited by 69
Goyenechea, E., Parra, M. D., & Martínez, J. A. (2006) · British Journal Of Nutrition · doi:10.1017/bjn20061901 · Cited by 73
“IL-6 is an important regulator of the acute-phase response that has been associated with obesity (Trayhurn & Wood, 2005) and with energy balance (Tsigos et al. 1997); it is released by adipocytes, as well as by other tissues (Trayhurn & Wood, 2004).”
BackgroundSimulated microgravity, psychic stress, and immune cells in men: observations during 120-day 6° HDT
Choukèr, A., Thiel, M., Baranov, V., Meshkov, D., Kotov, A., Peter, K., Messmer, K., & Christ, F. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.5.1736 · Cited by 59
“IL-6 is known to be secreted mainly at inflamed sites but also during stress.”
ResultInfluentialSuarez, E. C., Sundy, J. S., & Erkanli, A. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.008 · Cited by 62
“Although differences between patients and healthy controls are noteworthy, the validity of the CORT/CRP rests upon a large body of evidence for the bidirectional influences between the HPA axis and the immune system (Mastorakos et al., 1993; Mendelson and Glasgow, 1966; Tsigos et al., 1997).”
BackgroundGeenen, R., van Middendorp, H., & Bijlsma, J. W. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.007 · Cited by 64
Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes
Harder-Lauridsen, N. M., Krogh-Madsen, R., Holst, J. J., Plomgaard, P., Leick, L., Pedersen, B. K., & Fischer, C. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00571.2013 · Cited by 55
Straub, R. H., Härle, P., Sarzi‐Puttini, P., & Cutolo, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21946 · Cited by 55
Chiba, T., Yamaza, H., Higami, Y., & Shimokawa, I. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10211 · Cited by 53
“In humans, IL-6 administration has been shown to induce a dose-dependent increase in the resting metabolic rate and in hypothalamic-pituitary-adrenal axis activity (Tsigos et al., 1997).”
Sesti, G., Perego, L., Cardellini, M., Andreozzi, F., Ricasoli, C., Vedani, P., Guzzi, V., Marchi, M., Paganelli, M., Ferla, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0404 · Cited by 51
Sex Difference in Link between Interleukin-6 and Stress
Jankord, R., Turk, J. R., Schadt, J. C., Casati, J., Ganjam, V. K., Price, E. M., Keisler, D. H., & Laughlin, M. H. (2007) · Endocrinology · doi:10.1210/en.2006-1650 · Cited by 49
Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome
Minetto, M., Dovio, A., Ventura, M., Cappia, S., Daffara, F., Terzolo, M., & Angeli, A. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345202 · Cited by 50
Cerebrospinal fluid IL-6, HSP72, and TNF-α in exercising humans
Steensberg, A., Dalsgaard, M. K., Secher, N. H., & Pedersen, B. K. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.002 · Cited by 56
“Circulating IL-6 also stimulates the activity of the hypothalamic–pituitary–adrenal axis (Tsigos et al., 1997) and it is implicated in the induction of fever (Weber et al., 1993) and fatigue (Robson-Ansley et al., 2004) indicating that IL-6 has an eVect on the central nervous system (CNS).”
BackgroundŽarković, M., Ignjatović, S., Dajak, M., Ćirić, J., Beleslin, B., Savić, S., Stojković, M., Bulat, P., & Trbojević, B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0544 · Cited by 47
Gionis, D., Ilias, I., Moustaki, M., Mantzos, E., Papadatos, I., Koutras, D. A., & Mastorakos, G. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.49 · Cited by 47
Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man
Tsigos, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3379 · Cited by 50
Self-citationKatz, J., Taylor, N., Goodrick, S., Perry, L., Yudkin, J. S., & Coppack, S. W. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801122 · Cited by 48
IL6 as a mediator of insulin resistance: fat or fiction?
Allen, T. L., & Febbraio, M. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1627-x · Cited by 54
“Even without changes in food intake, IL6 has been shown to increase energy expenditure with both peripheral and central administration [10, 23, 24] and induces uncoupling protein 1 in brown adipose tissue through sympathetic innervation [25].”
BackgroundCancer cachexia: molecular basis and therapeutic advances
Tan, Y., Xue, R., Pan, Y., he, Z., Hu, X., Li, Y., Li, K., Zhang, X., Bian, X.-W., & Wang, B. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02331-7 · Cited by 67
Trinh, B., Peletier, M., Simonsen, C., Plomgaard, P., Karstoft, K., Klarlund Pedersen, B., van Hall, G., & Ellingsgaard, H. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100396 · Cited by 42
“Infusion of high doses of rhIL-6 into humans increases adrenocorticotropic hormone and cortisol levels.(36,37) To our knowledge, reduced cortisol levels after chronic IL-6 receptor blockade have not been reported previously.”
BackgroundJiang, Y., Zhang, W., Gao, F., & Zhou, G. (2015) · Canadian Journal of Animal Science · doi:10.4141/cjas-2014-183 · Cited by 51
Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance
Popko, K., Górska, E., & Demkow, U. A. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-s2-123 · Cited by 46
Metadata
- Authors
- Tsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- National and Kapodistrian University of Athens (GR)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-04-09
- Volume
- 66
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2081153263
- Cited by
- 223
- References
- 0
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 12
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- interleukin-6, dose-response relationship, pituitary hormone secretion, resting metabolic rate, energy expenditure, ACTH, cortisol, growth hormone, prolactin, thyroid-stimulating hormone, gonadotropins, hypothalamic-pituitary-adrenal axis, cytokines, vasopressin, corticotropin-releasing factor
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Arginine Vasopressin, Basal Metabolism, Calorimetry, Indirect, Dose-Response Relationship, Drug, Energy Metabolism, Humans, Hydrocortisone, Kinetics, Male, Pituitary Hormones, Prolactin, Recombinant Proteins, Thyrotropin, Interleukin-6, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.